Item Type | Name |
Concept
|
Chemical Industry
|
Concept
|
Industry
|
Concept
|
Food Industry
|
Concept
|
Tobacco Industry
|
Concept
|
Drug Industry
|
Academic Article
|
A cross-sectional analysis of pharmaceutical industry-funded events for health professionals in Australia.
|
Academic Article
|
Drug promotion.
|
Academic Article
|
Attitudes of academic and clinical researchers toward financial ties in research: a systematic review.
|
Academic Article
|
Sponsored symposia on environmental tobacco smoke.
|
Academic Article
|
Understanding the Nature and Extent of Pharmaceutical Industry Payments to Nonphysician Clinicians.
|
Academic Article
|
Mandatory disclosure of pharmaceutical industry-funded events for health professionals.
|
Academic Article
|
Industry sponsorship and research outcome.
|
Academic Article
|
The quality of drug studies published in symposium proceedings.
|
Academic Article
|
Pharmaceutical industry payments to leaders of professional medical associations in Australia: Focus on cardiovascular disease and diabetes.
|
Academic Article
|
Conflicts of interest between the sugary food and beverage industry and dental research organisations: time for reform.
|
Academic Article
|
A nicotine delivery device without the nicotine? Tobacco industry development of low nicotine cigarettes.
|
Academic Article
|
Conflicts of interest in academic research: policies, processes, and attitudes.
|
Academic Article
|
Tobacco industry research and protection of human subjects: a case study of R. J. Reynolds.
|
Academic Article
|
Tobacco use among individuals with schizophrenia: what role has the tobacco industry played?
|
Academic Article
|
Ten tips for spotting industry involvement in science policy.
|
Academic Article
|
Financial ties and concordance between results and conclusions in meta-analyses: retrospective cohort study.
|
Academic Article
|
Tobacco interests or the public interest: 20 years of industry strategies to undermine airline smoking restrictions.
|
Academic Article
|
The limits of competing interest disclosures.
|
Academic Article
|
Tobacco industry manipulation of research.
|
Academic Article
|
Policy makers' perspectives on tobacco control advocates' roles in regulation development.
|
Academic Article
|
Interactions between non-physician clinicians and industry: a systematic review.
|
Academic Article
|
The power of paperwork: how Philip Morris neutralized the medical code for secondhand smoke.
|
Academic Article
|
Term limits and the tobacco industry.
|
Academic Article
|
Identifying carcinogens: the tobacco industry and regulatory politics in the United States.
|
Academic Article
|
Commercial influence and covid-19.
|
Academic Article
|
Public health under attack: the American Stop Smoking Intervention Study (ASSIST) and the tobacco industry.
|
Academic Article
|
Industry sponsorship and research outcome: a Cochrane review.
|
Academic Article
|
Association of Industry Sponsorship With Outcomes of Nutrition Studies: A Systematic Review and Meta-analysis.
|
Academic Article
|
The Influence of Industry Sponsorship on the Research Agenda: A Scoping Review.
|
Academic Article
|
The creation of industry front groups: the tobacco industry and "get government off our back".
|
Academic Article
|
Does industry-sponsored education foster overdiagnosis and overtreatment of depression, osteoporosis and over-active bladder syndrome? An Australian cohort study.
|
Academic Article
|
Disclosure policies for gifts from industry to academic faculty.
|
Academic Article
|
Collaboration between academics and industry in clinical trials: cross sectional study of publications and survey of lead academic authors.
|
Academic Article
|
"Experimental" institutional models for corporate funding of academic research: unknown effects on the research enterprise.
|
Academic Article
|
"Asset exchange"-interactions between patient groups and pharmaceutical industry: Australian qualitative study.
|
Academic Article
|
Marketing and the Most Trusted Profession: The Invisible Interactions Between Registered Nurses and Industry.
|
Academic Article
|
Nonindustry-sponsored preclinical studies on statins yield greater efficacy estimates than industry-sponsored studies: a meta-analysis.
|
Academic Article
|
Association of industry ties with outcomes of studies examining the effect of wholegrain foods on cardiovascular disease and mortality: systematic review and meta-analysis.
|
Academic Article
|
Study sponsorship and the nutrition research agenda: analysis of randomized controlled trials included in systematic reviews of nutrition interventions to address obesity.
|
Academic Article
|
Financial ties and conflicts of interest between pharmaceutical and tobacco companies.
|
Academic Article
|
Characteristics and impact of drug detailing for gabapentin.
|
Academic Article
|
Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others.
|
Academic Article
|
The ties that bind.
|
Academic Article
|
Big Tobacco and Drugstore Chains: A Long, Cozy Relationship.
|
Academic Article
|
Toward a Healthier Patient Voice: More Independence, Less Industry Funding.
|
Academic Article
|
To give is better than to receive: compliance with WHO guidelines for drug donations during 2000-2008.
|
Academic Article
|
Outcome reporting in industry-sponsored trials of gabapentin for off-label use.
|
Academic Article
|
A Social Network Analysis of the Financial Links Backing Health and Fitness Apps.
|
Academic Article
|
Identifying barriers to the availability and use of Magnesium Sulphate Injection in resource poor countries: a case study in Zambia.
|
Academic Article
|
Ethical drug marketing criteria for the 21st century.
|
Academic Article
|
How the tobacco industry responded to an influential study of the health effects of secondhand smoke.
|
Academic Article
|
Assessing faculty financial relationships with industry: A case study.
|
Academic Article
|
The tobacco industry and the Data Quality Act.
|
Academic Article
|
Dear doctor ... regarding calcium channel blockers.
|
Academic Article
|
Lessons learned from the tobacco industry's efforts to prevent the passage of a workplace smoking regulation.
|
Academic Article
|
The publication of sponsored symposiums in medical journals.
|
Academic Article
|
Tobacco industry efforts to defeat the occupational safety and health administration indoor air quality rule.
|
Academic Article
|
Implementation of a workplace smoking ban in bars: the limits of local discretion.
|
Academic Article
|
The cigar revival and the popular press: a content analysis, 1987-1997.
|
Academic Article
|
Influences on the quality of published drug studies.
|
Academic Article
|
Industry sponsorship and publication bias among animal studies evaluating the effects of statins on atherosclerosis and bone outcomes: a meta-analysis.
|
Academic Article
|
Conflicts of interest in approvals of additives to food determined to be generally recognized as safe: out of balance.
|
Academic Article
|
Industry-funded research and conflict of interest: an analysis of research sponsored by the tobacco industry through the Center for Indoor Air Research.
|
Academic Article
|
Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments.
|
Academic Article
|
Pharmaceutical industry sponsorship and research outcome and quality: systematic review.
|
Academic Article
|
Expanding disease definitions in guidelines and expert panel ties to industry: a cross-sectional study of common conditions in the United States.
|
Academic Article
|
Reporting of financial conflicts of interest in meta-analyses of drug trials published in high-impact medical journals: comparison of results from 2017 to 2018 and 2009.
|
Academic Article
|
Pharmaceutical industry funding of events for healthcare professionals on non-vitamin K oral anticoagulants in Australia: an observational study.
|
Academic Article
|
Tobacco industry sponsorship of a book and conflict of interest.
|
Academic Article
|
[Shall we ban industrial funds for research?].
|
Academic Article
|
Interpreting evidence in general practice: Bias and conflicts of interest.
|
Academic Article
|
Philip Morris involvement in the development of an air quality laboratory in El Salvador.
|
Academic Article
|
Characteristics of materials distributed by drug companies. An evaluation of appropriateness.
|
Academic Article
|
Chasing the dollar: why scientists should decline tobacco industry funding.
|
Academic Article
|
Narrative review: the promotion of gabapentin: an analysis of internal industry documents.
|
Academic Article
|
Tobacco industry denormalisation as a tobacco control intervention: a review.
|
Academic Article
|
Changes in the type and amount of spending disclosed by Australian pharmaceutical companies: an observational study.
|
Academic Article
|
Moral disengagement in the corporate world.
|
Academic Article
|
Randomized trials assessing calcium supplementation in healthy children: relationship between industry sponsorship and study outcomes.
|
Academic Article
|
Industry sponsorship and research outcome.
|
Academic Article
|
The relationship between study sponsorship, risks of bias, and research outcomes in atrazine exposure studies conducted in non-human animals: Systematic review and meta-analysis.
|
Academic Article
|
Undisclosed financial ties between guideline writers and pharmaceutical companies: a cross-sectional study across 10 disease categories.
|
Academic Article
|
Pharmaceutical industry funding of educational events for pharmacists in Australia: an analysis of data from the first 6 months of a mandatory disclosure programme.
|
Academic Article
|
A clearer view of evidence in treating macular degeneration: off-label policies and independent research.
|
Academic Article
|
Cigar magazines: using tobacco to sell a lifestyle.
|
Academic Article
|
Mixed methods evaluation of workshops for citizen health advocates about financial conflicts of interests in healthcare.
|
Academic Article
|
The role of public participation in public health initiatives: an analysis of the WHO Framework Convention on Tobacco Control.
|
Academic Article
|
Reporting of drug trial funding sources and author financial conflicts of interest in Cochrane and non-Cochrane meta-analyses: a cross-sectional study.
|
Academic Article
|
Addressing Bias and Conflict of Interest Among Biomedical Researchers.
|
Academic Article
|
The Inclusion of Nurses in Pharmaceutical Industry-Sponsored Events: Guess Who Is Also Coming to Dinner?
|
Academic Article
|
Bias related to funding source in statin trials.
|
Academic Article
|
Public Opinions about Overdiagnosis: A National Community Survey.
|
Academic Article
|
Financial ties between leaders of influential US professional medical associations and industry: cross sectional study.
|
Academic Article
|
Industry sponsorship and research outcome: systematic review with meta-analysis.
|
Academic Article
|
The publication of commercially supported supplements statement.
|
Academic Article
|
Food industry sponsorship of academic research: investigating commercial bias in the research agenda.
|
Academic Article
|
Nicotine and addiction. The Brown and Williamson documents.
|
Academic Article
|
Lawyer control of internal scientific research to protect against products liability lawsuits. The Brown and Williamson documents.
|
Academic Article
|
How can the integrity of occupational and environmental health research be maintained in the presence of conflicting interests?
|
Academic Article
|
Legislating "sound science": the role of the tobacco industry.
|
Academic Article
|
Why the Cochrane risk of bias tool should include funding source as a standard item.
|
Academic Article
|
Looking through a keyhole at the tobacco industry. The Brown and Williamson documents.
|
Academic Article
|
Lawyer control of the tobacco industry's external research program. The Brown and Williamson documents.
|
Academic Article
|
Environmental tobacco smoke. The Brown and Williamson documents.
|
Academic Article
|
"A delicate diplomatic situation": tobacco industry efforts to gain control of the Framingham Study.
|
Academic Article
|
Philip Morris International-funded 'Foundation for a Smoke-Free World': analysing its claims of independence.
|
Grant
|
Management Decisions in Financial Conflicts of Interest
|
Grant
|
Measuring Design, Reporting and Funding Bias in Nonclinical Research
|
Grant
|
DEVELOPING POLICY TO REVERSE THE CIGAR TREND
|
Academic Article
|
Mechanisms for addressing and managing the influence of corporations on public health policy, research and practice: a scoping review.
|
Academic Article
|
Industry payments to Australian medical oncologists and clinical haematologists: a cross-sectional analysis of publicly available disclosures.
|
Academic Article
|
"There are ways ? drug companies will get into DTC decisions": How Australian drug and therapeutics committees address pharmaceutical industry influence.
|
Academic Article
|
Association of food industry ties with findings of studies examining the effect of dairy food intake on cardiovascular disease and mortality: systematic review and meta-analysis.
|
Academic Article
|
Conflicts of interest in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: associations with recommendations.
|
Academic Article
|
'Lines in the sand': an Australian qualitative study of patient group practices to promote independence from pharmaceutical industry funders.
|
Academic Article
|
Association Between Conflicts of Interest and Authors' Positions on Harms of Varenicline: a Cross-Sectional Analysis.
|
Academic Article
|
Risky business? Pharmaceutical industry sponsorship of health consumer groups.
|
Academic Article
|
Interactions with the pharmaceutical industry and the practice, knowledge and beliefs of medical oncologists and clinical haematologists: a systematic review.
|
Academic Article
|
Pharmaceutical industry payments and assisted reproduction in Australia: a retrospective observational study.
|
Academic Article
|
Australian Cancer Physicians and the Pharmaceutical Industry: A Survey of Attitudes and Interactions.
|
Academic Article
|
Branded Care: The Policy Implications of Pharmaceutical Industry-Funded Nursing Care Related to Specialty Medicines.
|
Academic Article
|
Interactions between Australian cancer physicians and the pharmaceutical industry: a qualitative study.
|
Academic Article
|
The Devil they Knew: Chemical Documents Analysis of Industry Influence on PFAS Science.
|
Academic Article
|
Characteristics of Advanced Practice Nurses Receiving Top Industry Payments and Their Practice Settings: a Cross-sectional Study.
|
Academic Article
|
Corporate Influences on Science and Health-the Case of Spinal Cord Stimulation.
|